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Supplementary Figure 1. Additional examples of genes within the 
three groups of TNF-activated genes. 3T3 fibroblasts were stimulated 
with TNF (10 ng/ml). At indicated times after addition of TNF, mRNA 
transcripts encoding genes in each group were measured by RT-qPCR 
and normalized to Rpl32 as described in Methods. The results are 
shown as mean ± s.d. of triplicate samples and representative of four 
independent experiments with similar results. 
 
Supplementary Figure 2. Kinetic patterns of TNF-induced gene 
expression in human dermal primary fibroblasts. Cells were exposed to 
continual TNF (10 ng/ml) stimulation (TNF; solid diamond), or to 6 
hours of TNF followed by medium alone (TNF removal; open square). 
At indicated times after initial addition of TNF, mRNA transcripts 
encoding indicated genes were measured by RT-qPCR and normalized 
to Rpl32 as described in Methods. However, Rpl32 in these cells was 
expressed in approximately 100-fold lower amounts than in 3T3 cells. 
Note that only one time point was taken after removal of TNF so the 
kinetics of the drop in mRNA concentration are not evident. The results 
are shown as mean ± s.d. of triplicate samples from one 
representative experiment. Numbers in parentheses show the half life 
of the mRNA, determined by addition to ActD at 6h following TNF 
stimulation, which is similar to that determined at 0.5h of TNF 
stimulation for most genes (data not shown) 
 
Supplementary Figure 3. Effect of TNF concentration on gene 
expression patterns.   3T3 fibroblasts were treated with 10 ng/ml (solid 
diamond) or 1 ng/ml (open square) TNF and mRNA transcripts 
encoding indicated genes were measured by qRT-PCR. The data are 
mean ± s.d. of triplicate samples and representative of three 
independent experiments with similar results. 
 
Supplementary Figure 4. Schematic of GFP transgene constructs 
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Supplementary Table 1.  List of the three groups of genes 
 
Group I genes,  (fold>=2.0, p<0.01) 
Gene 






    0.5h 2h 12h 
Blood vessel regulators      
Ptgs2 Cox-2 M94967 1.59 2.01 -1.46 -2.94 
Edn1 endothelin 1 D43775 0.30 3.98 -1.19 1.02 
Ereg epiregulin NM_007950 1.72 2.12 1.32 -1.08 
Cell death, survival      
Gadd45b growth arrest and DNA-damage-inducible 
45 beta AK010420 1.80 3.16 2.36 1.69 
Ier2 immediate early response 2 NM_010499 1.20 2.35 -1.18 -1.82 
Chemokine or cytokine      
Cxcl1 Gro1 NM_008176 0.70 28.08 11.98 6.20 
Cxcl2 Scyb2 NM_009140 0.02 44.86 9.09 3.59 
Il6 interleukin 6 NM_031168 0.31 14.20 8.40 6.30 
Lif leukemia inhibitory factor AF065917 0.17 5.69 3.41 2.06 
mRNA stability      
Btg2 B-cell translocation gene 2 NM_007570 0.24 3.07 1.22 -2.19 
Zfp36 TTP X14678 0.49 6.65 1.84 -1.04 
Signal transduction      
Tnfaip3 A20 NM_009397 1.41 9.71 5.99 2.51 
Ier3 immediate early response 3 NM_133662.1 5.34 4.08 2.49 1.93 
Sqstm1 sequestosome 1 NM_011018 0.36 2.04 1.48 -1.00 
Transcription factors or modulators      
Atf3 activating transcription factor 3 NM_007498 0.38 2.04 1.62 1.95 
Axud1 Axud1 BG070296 0.31 2.45 -1.66 -4.62 
c-Jun Jun oncogene NM_010591 2.69 2.00 1.01 -1.10 
c-Fos FBJ osteosarcoma oncogene AV026617 0.49 4.71 -1.92 -6.42 
Ifrd1 interferon-related developmental regulator 1 BB531645 0.15 3.51 1.60 -1.14 
Nfkbia IkBa NM_010907 1.42 10.03 7.47 3.63 
Nfkbiz IkBzeta NM_030612 0.62 5.71 3.63 2.00 
Irf1 interferon regulatory factor 1 NM_008390 0.77 7.69 5.41 2.86 
Junb Jun-B oncogene NM_008416 1.44 2.14 1.12 -1.83 
Tieg TGFB inducible early growth response NM_013692 1.91 2.26 1.18 -1.86 
Others       
Slc25a25 solute carrier family 25  BC019978.1 0.28 2.35 1.15 -1.29 
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Supplementary Table 1.  Continued 
 
Group II genes  
(only those fold>=3, p<0.01 are shown) 
   
Gene  






    0.5h 2h 12h 
Anti-viral and immune response      
Ifi47 interferon gamma inducible protein, 47 kDa NM_008330 0.02 3.50 37.17 20.91 
Tgtp T-cell specific GTPase NM_011579 0.03 1.36 24.75 9.73 
Blood vessel regulators      
Gch GTP cyclohydrolase 1 NM_008102 0.16 1.24 6.11 5.67 
Cell adhesion and migration      
Icam1 intercellular adhesion molecule 1 BC008626 0.03 3.09 30.01 22.70 
Vcam1 vascular cell adhesion molecule 1 BB250384 1.29 2.34 5.30 4.36 
Cell death and survival      
Birc2 baculoviral IAP repeat-containing 2 NM_007464 0.35 1.53 5.25 6.27 
Tnfrsf6 Fas NM_007987 0.50 1.11 3.54 2.66 
Chemokines or cytokines      
Ccl2 MCP-1, Scya2 AF065933 0.74 9.10 17.44 19.62 
Ccl20 MIP-3a, Scya20 AF099052 0.02 100 100 100 
Ccl7 MCP-3, Scya7 AF128193 0.34 5.90 10.53 14.09 
Cx3cl1 Scyd1, Fractalkine AF010586 0.88 1.90 4.82 2.62 
Cxcl10 IP-10, Scyb10 NM_021274 0.26 10.91 31.91 17.03 
Cxcl5 ENA-78, Scyb5 NM_009141 2.87 2.93 3.36 2.72 
CSF1 colony stimulating factor 1 (macrophage) NM_007778 2.53 1.90 3.00 2.10 
Ch25h cholesterol 25-hydroxylase NM_009890 0.09 7.87 15.15 13.50 
Signal transduction      
Ifngr2 Interferon gamma receptor 2 BF537076 0.25 1.26 3.01 3.04 
p21 cyclin-dependent kinase inhibitor 1A (P21) NM_007669 0.21 2.46 4.26 1.19 
Ripk2 RIP2, NM_138952.1 0.44 1.62 8.22 2.41 
S1pr3 sphingosine-1-phosphate receptor 3 AV238324 0.54 1.37 3.36 3.11 
Tlr2 toll-like receptor 2 NM_011905 0.66 2.67 7.30 4.79 
Cebpd CEBP beta BB831146 1.78 1.22 4.36 1.93 
Nfkbie IkBe BB820441 0.15 3.03 28.35 20.00 
Relb  NM_009046 0.09 2.78 9.40 8.05 
Tnfaip2 B94 BB233088 0.72 1.53 3.83 1.95 
Npal1 RIKEN cDNA 3830408G10 gene AK014427 0.23 1.42 3.14 1.24 
Rnd1  BE852181 0.99 2.67 3.16 3.25 
Tmem140 transmembrane protein 140  BC020080.1 0.44 1.04 3.32 2.36 
Stx11 RIKEN cDNA 5830405C08 gene AK017897 0.52 1.82 4.71 2.23 
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Supplementary Table 1.  Continued 
 
Group III genes 
(only those fold >=3, p<0.01 are shown) 






    0.5h 2h 12h 
Antigen presentation      
H2-D1 histocompatibility 2, D region locus 1 M86502 1.29 1.20 1.75 4.02 
H2-K histocompatibility 2, K region BC011306 0.37 1.02 2.56 29.68 
H2-L histocompatibility 2, L region M34962 0.23 1.30 1.70 3.66 
Ii Ia-associated invariant chain BC003476 0.16 1.05 2.49 7.31 
Psmb10 proteasome subunit, beta type 10 NM_013640 0.81 1.13 2.52 5.02 
Tapbp TAP binding protein AF043943 4.55 1.08 1.74 3.11 
Anti-viral and immune response      
C3 complement component 3 K02782 0.07 2.65 6.14 55.51 
Gbp2 guanylate nucleotide binding protein 2 NM_010260 0.06 1.26 7.69 36.09 
Ifit1 interferon-induced protein with 
tetratricopeptide repeats 1 NM_008331 0.10 -1.00 2.40 5.84 
Cell adhesion and migration      
Casp4 caspase 11 NM_007609 0.04 1.86 7.81 18.72 
Cdsn corneodesmosin  BM231053 0.61 1.08 1.65 5.89 
Cell death and survival      
Mt2 metallothionein 2 AA796766 1.35 1.58 3.14 5.24 
Sod3 superoxide dismutase 3, extracellular NM_011435 0.27 1.13 1.67 3.04 
Serpina3g serine protease inhibitor 2-1,  BC002065 0.06 1.11 5.65 19.18 
Ubd ubiquitin D NM_023137 0.09 -1.08 1.71 9.14 
Chemokines and cytokines      
Ccl5 RANTES, Scya5 NM_013653 0.02 -1.74 33.6 100 
Ccl9 small inducible cytokine A9 AF128196 0.24 1.41 2.47 4.11 
Lcn2 lipocalin 2 X14607 0.16 -1.42 1.01 4.81 
Signaling transduction      
Il13ra1 IL13 receptor a1 BI081033 0.19 1.02 2.17 3.44 
Il1rl1 interleukin 1 receptor-like 1 NM_010743 0.88 1.25 2.35 6.13 
Naf1 Nef-associated factor 1, Abin-1 AJ242777 1.00 1.01 2.41 4.30 
Tissue remodeling and wound healing      
Enpp2 ectonucleotide 
pyrophosphatase/phosphodiesterase 2 BC003264 0.30 1.08 1.74 13.07 
Mmp13 matrix metalloproteinase 13 NM_008607 0.15 1.53 4.86 16.48 
Mmp3 matrix metalloproteinase 3 NM_010809 1.37 1.20 1.86 6.57 
Serpinf1 , PEDF NM_011340 2.18 1.09 1.26 4.08 
Ppicap peptidylprolyl isomerase C-associated protein NM_011150 0.20 1.17 1.20 3.07 
Others (unknown function)      
1110004C05Rik RIKEN cDNA 1110004C05 gene BC010291 3.38 1.24 1.97 3.77 
Abca1 ATP-binding cassette, sub-family A1 BB144704 0.07 2.07 2.30 7.08 
AI561871 expressed sequence AI561871 BI143915 0.17 -1.20 1.51 5.08 
AI882074 expressed sequence AI882074 BB730912 0.09 1.29 3.32 5.91 
Arts1 ESTs AV287655 0.10 1.16 1.83 3.59 
Lhfpl2 lipoma HMGIC fusion partner-like 2 BG917242 0.02 1.82 6.77 23.29 
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LOC677168 cDNA, RIKEN  clone:2900034J12,  AK019325 0.25 -1.06 2.32 5.91 
AW049765  BC026642.1 0.10 -1.41 2.57 21.95 
Prnd prion protein dublet AF165166 0.02 1.18 3.38 28.41 





Supplementary Table 2. Stability of mRNA transcripts measured 
using two different approaches 
 
 
mRNA stability  (half life, h, mean ± s.d., n=3 ) 
  Genes  6h TNF pretreatment 
    TNFa removal ActD treatment 
 Group II Ccl20  1.30 ± 0.12 3.33 ± 1.02 
  Ccl2  1.38 ± 0.09 0.82 ± 0.01 
  Ccl7  1.56 ± 0.21 1.32 ± 0.06 
  Tlr2  1.93 ± 0.25 1.27 ± 0.32 
  Nfkbie  1.69 ± 0.07 1.90 ± 0.13 
  Cxcl10  1.87 ± 0.05 1.92 ± 0.05 
  Icam1  1.66 ± 0.20 2.30 ± 0.56 
  CSF1  5.33 ± 2.51 2.60 ± 0.43 
  Mmp10  10.5 ± 18.0 stable 
      
 Group III Ifit1  stable 1.97 ± 1.22 
  Stat1  9.76 ± 18.5 11.7 ± 12.7 
  C3  stable stable 
  Ccl5  stable stable 
  Mmp13  stable stable 
  Mmp3  stable stable 
  Saa3  stable stable 
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Supplementary Table 3.  Sequneces of qPCR primers 
 
name  alias species primer name sequence 
Tnfaip3 A20 mouse A20_(1)_F GAACAGCGATCAGGCCAGG 
   A20_(1)_R GGACAGTTGGGTGTCTCACATT 
actb β-actin mouse actin_F AGGTGTGCACCTTTTATTGGTCTCAA 
   actin_R TGTATGAAGGTTTGGTCTCCCT 
C3 Complement 3 mouse C3_(2)_F CTGAGAAGCGTCTCCATCAAG 
   C3_(2)_R ACGGGCAGTAGGTTGTTGTC 
Ccl2 MCP-1 mouse Ccl2_F CTGAAGACCTTAGGGCAGAT 
   Ccl2_R AAGGAATGGGTCCAGACATAC 
Ccl20 MIP-3α mouse CCL20_F GCCTCTCGTACATACAGACGC 
   CCL20_R CCAGTTCTGCTTTGGATCAGC 
Ccl5 Rantes mouse Ccl5_(1)_F GCTGCTTTGCCTACCTCTCC 
   Ccl5_(1)_F TCGAGTGACAAACACGACTGC 
Ccl7 MCP-3 mouse CCL7_(1)_F GCTGCTTTCAGCATCCAAGTG 
   CCL7_(1)_R CCAGGGACACCGACTACTG 
Ptgs2 COX-2 mouse COX-2_F TGAGCAACTATTCCAAACCAGC 
   COX-2_R GCACGTAGTCTTCGATCACTATC 
CSF1 M-CSF mouse CSF1_(2)_F AGTCAACAGAGCAACCAAACC 
   CSF1_(2)_R CAAAAATCCCTCACTAGCCTCTC 
Cxcl1 KC mouse Cxcl1_(1)_F CTGGGATTCACCTCAAGAACATC 
   Cxcl1_(1)_R CAGGGTCAAGGCAAGCCTC 
Cxcl10 IP-10  mouse Cxcl10_F  AGGACGGTCCGCTGCAA 
   Cxcl10_R  CATTCTCACTGGCCCGTCAT 
Cxcl2 MIP-2 mouse Cxcl2_(1)_F CCCTCAACGGAAGAACCAAAG 
   Cxcl2_(1)_R TTCCCGGGTGCTGTTTGT 
Edn1 endothelin-1 mouse ET-1_(1)_F GCACCGGAGCTGAGAATGG 
   ET-1_(1)_R GTGGCAGAAGTAGACACACTC 
Fos c-Fos mouse Fos_(2)_F CCCATCCTTACGGACTCCC 
   Fos_(2)_R GAGATAGCTGCTCTACTTTGCC 
Icam1 ICAM1 mouse ICAM1_F TGTCAGCCACTGCCTTGGTA 
   ICAM1_R CAGGATCTGGTCCGCTAGCT 
Ifit1 Ifit1 mouse Ifit1_(1)_F CTGAGATGTCACTTCACATGGAA 
   Ifit1_(1)_R GTGCATCCCCAATGGGTTCT 
Nfkbia IkBα mouse IkBa_F CTGCAGGCCACCAACTACAA 
   IkBa_R CAGCACCCAAAGTCACCAAGT  
Nfkbie IkBε mouse IkBe_(1)_F TGGACCTCCAACTGAAGAACT 
   IkBe_(1)_R TTCCTCTGCAATGTGGCAATG 
Il1b interleukin-1β mouse IL-1b_(1)_F GCAACTGTTCCTGAACTCAACT 
   IL-1b_(1)_R ATCTTTTGGGGTCCGTCAACT 
IL6 interleukin 6 mouse IL6_F TAGTCCTTCCTACCCCAATTTCC 
   IL6_R TTGGTCCTTAGCCACTCCTTC 
Irf1 Irf1 mouse IRF1_(2)_F AGGCCGATACAAAGCAGGAGA 
   IRF1_(2)_R GCTGCCCTTGTTCCTACTCTG 
Jun c-Jun mouse Jun_(2)_F ACTCGGACCTTCTCACGTC 
   Jun_(2)_R CGGTGTAGTGGTGATGTGCC 
Rpl32 L32 mouse L32_F AAGCGAAACTGGCGGAAAC 
   L32_R TAACCGATGTTGGGCATCAG 
Mmp10 MMP-10 mouse MMP-10_(2)_F AACACGGAGACTTTTACCCTTTT 
   MMP-10_(2)_R GGTGCAAGTGTCCATTTCTCAT 
Mmp13 MMP-13 mouse MMP-13_(2)_F ACCTCCACAGTTGACAGGCT 
   MMP-13_(2)_R AGGCACTCCACATCTTGGTTT 
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Supplementary Table 3.  Continued 
 
 
name  alias species primer name sequence 
Mmp3 MMP-3 mouse MMP-3_(2)_F TGTCCCGTTTCCATCTCTCTC 
   MMP-3_(2)_R TGGTGATGTCTCAGGTTCCAG 
Saa3 Saa3 mouse Saa3_(1)_F TGCCATCATTCTTTGCATCTTGA 
   Saa3_(1)_R CCGTGAACTTCTGAACAGCCT 
Serpina3g Spi2A mouse Spi2A_(1)_F CTTCCCAACGGCTGGAATCTA 
   Spi2A_(1)_R ACTGTCCAATCAGGCATAGCG 
TLR2 TLR2 mouse TLR2_(3)_F CCAGACACTGGGGGTAACATC 
   TLR2_(3)_R CGGATCGACTTTAGACTTTGGG 
Tnf TNFα mouse TNF_F CTACTCCCAGGTTCTCTTCAA 
   TNF_R GCAGAGAGGAGGTTGACTTTC 
Vcam1 Vcam1 mouse Vcam1_(1)_F AGTTGGGGATTCGGTTGTTCT 
   Vcam1_(1)_R CCCCTCATTCCTTACCACCC 
Zfp36 TTP mouse Zfp36_(1)_F TCTCTGCCATCTACGAGAGCC 
   Zfp36_(1)_R CCAGTCAGGCGAGAGGTGA 
Zfp36 TTP mouse Zfp36_(2)_F TCGAAGAGACCCTAACCAGGC 
   Zfp36_(2)_R GCGTAGTCATCAGGATCGGA 
C3 C3 human hC3_(1)_F CCTGCTACTAACCCACCTCC 
   hC3_(1)_R AACAGTGACTGGAACATCCCC 
CCL2 MCP-1 human hCCL2_(1)_F CAGCCAGATGCAATCAATGCC 
   hCCL2_(1)_R TGGAATCCTGAACCCACTTCT 
CCL5 Rantes human hCCL5_ F CCCAGCAGTCGTCTTTGTCA 
   hCCL5_ R TCCCGAACCCATTTCTTCTCT 
CXCL1 CXCL1 human hCXCL1_ F CTGCGCTGCCAGTGCTTGCA 
   hCXCL1_ R TGTGGCTATGACTTCGGTTTG 
CXCL10 IP-10 human hCXCL10_(1)_F GTGGCATTCAAGGAGTACCTC 
   hCXCL10_(1)_R GCCTTCGATTCTGGATTCAGACA 
FOS c-FOS human hFOS_(3)_F GGGCAAGGTGGAACAGTTATC 
   hFOS_(3)_R CCGCTTGGAGTGTATCAGTCA 
GAPDH GAPDH human hGAPDH_F AACAGCGACACCCACTCCTC 
   hGAPDH_R CATACCAGGAAATGAGCTTGACAA 
ICAM1 ICAM1 human hICAM1_(1)_F TCTGTGTCCCCCTCAAAAGTC 
   hICAM1_(1)_R GGGGTCTCTATGCCCAACAA 
NFKBIA IkBα human hIkBa_(1)_F CTCCGAGACTTTCGAGGAAATAC 
   hIkBa_(1)_R GCCATTGTAGTTGGTAGCCTTCA 
IL6 Interleukin6 human hIL-6_(1)_F AAATTCGGTACATCCTCGACGG 
   hIL-6_(1)_R GGAAGGTTCAGGTTGTTTTCTGC 
Rpl32 Rpl32 human hL32_F AGCTCCCAAAAATAGACGCAC 
   hL32_R TTCATAGCAGTAGGCACAAAGG 
GFP GFP  GFP_(BMC)_F GGAGCGCACGATCTTCTTCA 
   GFP_(BMC)_R AGGGTGTCGCCCTCGAA 
GFP GFP  GFP_(6)_F ACTTCAAGATCCGCCACAACA 
   GFP_(6)_R TGGGTGCTCAGGTAGTGGTTG 
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